Anton Bespalov presented a webinar “Rigor in preclinical ​drug discovery research:​ Why not?​” for the VICT3R consortium. This webinar took a critical look at the origins and consequences of low rigor in preclinical studies and dived into practical barriers that prevent or slow down the adoption of essential practices like randomization and blinding. With experience spanning PAASP, EQIPD, and the ECNP Preclinical Data Forum, Anton brought insights on what’s at stake and what needs to change. 

(Link to recorded video)